These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1203 related articles for article (PubMed ID: 17255760)

  • 41. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
    Medeiros F; Muto MG; Lee Y; Elvin JA; Callahan MJ; Feltmate C; Garber JE; Cramer DW; Crum CP
    Am J Surg Pathol; 2006 Feb; 30(2):230-6. PubMed ID: 16434898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
    Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
    J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Unique case of primary squamous carcinoma of the salpinx associated with serous carcinoma of the omentum: a pathological and molecular study.
    Giordano G; D'Adda T; Brigati F; Lombardi M; Raboni S
    Int J Gynecol Pathol; 2010 Nov; 29(6):533-8. PubMed ID: 20881860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.
    Crum CP; Drapkin R; Kindelberger D; Medeiros F; Miron A; Lee Y
    Clin Med Res; 2007 Mar; 5(1):35-44. PubMed ID: 17456833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].
    Škapa P; Dundr P
    Cesk Patol; 2016; 52(4):199-204. PubMed ID: 27869446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.
    Shaw PA; Rouzbahman M; Pizer ES; Pintilie M; Begley H
    Mod Pathol; 2009 Sep; 22(9):1133-8. PubMed ID: 19543244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
    Gilks CB; Irving J; Köbel M; Lee C; Singh N; Wilkinson N; McCluggage WG
    Am J Surg Pathol; 2015 Mar; 39(3):357-64. PubMed ID: 25517954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data.
    Vang R; Shih IeM; Salani R; Sugar E; Ayhan A; Kurman RJ
    Am J Surg Pathol; 2008 Nov; 32(11):1667-74. PubMed ID: 18769340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.
    Tone AA; Begley H; Sharma M; Murphy J; Rosen B; Brown TJ; Shaw PA
    Clin Cancer Res; 2008 Jul; 14(13):4067-78. PubMed ID: 18593983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube.
    Mehrad M; Ning G; Chen EY; Mehra KK; Crum CP
    Adv Anat Pathol; 2010 Sep; 17(5):293-302. PubMed ID: 20733351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of p-ERM, a marker of cell polarity, in benign and neoplastic oviductal epithelium.
    Ning G; Bijron JG; Yuan J; Hirsch MS; McKeon FD; Nucci MR; Crum CP; Xian W
    Int J Gynecol Pathol; 2013 Jul; 32(4):345-52. PubMed ID: 23722506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
    Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ
    Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-grade and low-grade pelvic serous neoplasms demonstrate differential p53 immunoreactivity in peritoneal washings.
    Chang MC; Cibas ES; Crum CP; Kindelberger DW
    Acta Cytol; 2011; 55(1):79-84. PubMed ID: 21135526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Serous genital carcinoma: molecular pathogenesis and the role of tubal fimbria].
    Lax S
    Pathologe; 2009 Dec; 30 Suppl 2():210-6. PubMed ID: 19859709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.
    Howitt BE; Hanamornroongruang S; Lin DI; Conner JE; Schulte S; Horowitz N; Crum CP; Meserve EE
    Am J Surg Pathol; 2015 Mar; 39(3):287-93. PubMed ID: 25581732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma.
    Nik NN; Vang R; Shih IeM; Kurman RJ
    Annu Rev Pathol; 2014; 9():27-45. PubMed ID: 23937438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
    Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.
    Singh N; Faruqi A; Kommoss F; McCluggage WG; Trevisan G; Senz J; Lum A; Gilks CB; Anglesio M
    Mod Pathol; 2018 Apr; 31(4):652-659. PubMed ID: 29148539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria.
    Semmel DR; Folkins AK; Hirsch MS; Nucci MR; Crum CP
    Mod Pathol; 2009 Aug; 22(8):985-8. PubMed ID: 19407856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.